Dr. Kumar received his PhD from the Indian Institute of Science, Bangalore, India for his work on DNA repair in Mycobacteria and MSc in Animal Biotechnology from the National Dairy Research Institute, Karnal, India. Dr. Kumar joined New Jersey Medical School in 2011 after his postdoctoral training in anti-TB drug discovery with Prof. Clifton Barry at the National Institutes of Health, Bethesda, MD. Current focus of his research is on developing pathway based screens to identify and validate novel druggable targets in Mycobacterium tuberculosis. He uses biochemical, genetic, genomic, metabolomics and chemical biology tools to understand mechanism of action of novel anti-TB compounds aimed at developing screening hits into viable lead compounds geared towards targeting multi-drug resistant TB. He is also studying mechanisms underlying drug resistance and persistence in Mycobacterium tuberculosis.
Education
PHD, 2005, Indian Institute of Science, Bangalore, Karnataka, India
